From the *EA 73-28, Université de Paris
†AP-HP, Hospital Necker-E.M., Virology Department, Reference Laboratory for Cytomegalovirus Infections, Paris, France
‡AP-HP, Hospital Bicêtre, Neonatal Intensive Care Unit, Le Kremlin-Bicêtre, France
§INSERM, U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Center; and Medicine and Neonatal Intensive Care Unit, Groupe Hospitalier Paris Saint Joseph, Paris, France
¶AP-HP, Hospital Necker-E.M., Neonatal Intensive Care Unit, Université de Paris, Paris, France
‖Hospital Intercommunal Poissy-Saint Germain, Maternity, Poissy, France
**AP-HP, Hospital Cochin, Maternity, Paris, France
††AP-HP, Hospital Bicêtre, Otology Department, Le Kremlin-Bicêtre, France
‡‡Hospital Saint Joseph, Otology Department, Paris, France
§§AP-HP, Hospital Necker-E.M., Clinical Research Unit
¶¶AP-HP, Hospital Necker-E.M., Maternity
‖‖AP-HP, Hôpital Ambroise Paré, Unité de Recherche Clinique, Paris Saclay Ouest, Boulogne, France
***AP-HP, Hospital Necker-E.M, Otology Department, Paris, France.
Accepted for publication January 9, 2022
Clinical trial registration number: NCT02139423.
Y.V. declares receiving fees for lectures from General Electric outside this work. M.L.-V. declares having received fees paid to her institution for expertise of diagnosis kits and for lectures from BioMérieux and Diasorin outside this work and for participating to conferences from Abbott and Roche. The other authors have no conflicts of interest to disclose.
J.F. and M.L.-V. involved in investigation, methodology, and writing—original draft. L.B. involved in conceptualization, methodology, supervision, and writing—review and editing. Y.V. involved in supervision and writing—review. L.N. involved in statistical analysis—review. L.G. involved in methodology—review. T.G. involved in realization of laboratory technics and data acquisition—review. C.B., E.W., E.K., S.C., and S.P. involved in inclusion of patients in the study, data acquisition, review, and editing. C.P., C.M., and M.P. involved in hearing loss assessment, data acquisition, review, and editing. All authors edited and approved the final article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Jacques Fourgeaud, PharmaD, Hospital Necker-E.M., Virology Department, 149 rue de Sèvres, 75015 Paris, France. E-mail: [email protected].
